Sergey Avtushenko
Direttore/Membro del Consiglio presso PHARMSYNTHEZ
Profilo
Sergey Sergeevich Avtushenko is currently the Director at Pharmsynthez PJSC and the Director at SynBio LLC.
Previously, he worked as the Executive Director at H & H LLC from 2003 to 2007 and as a Member-Management Board at Pharmavit Holding.
Mr. Avtushenko completed his undergraduate degree at Pavlov First Saint Petersburg State Medical University.
Posizioni attive di Sergey Avtushenko
| Società | Posizione | Inizio |
|---|---|---|
| PHARMSYNTHEZ | Direttore/Membro del Consiglio | - |
SynBio LLC
 SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Sergey Avtushenko
| Società | Posizione | Fine |
|---|---|---|
| H & H LLC | Direttore/Membro del Consiglio | 01/01/2007 |
| Pharmavit Holding | Corporate Officer/Principal | - |
Formazione di Sergey Avtushenko
| Pavlov First Saint Petersburg State Medical University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHARMSYNTHEZ | Health Technology |
| Aziende private | 3 |
|---|---|
| H & H LLC | |
| Pharmavit Holding | |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
- Borsa valori
- Insiders
- Sergey Avtushenko
